ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO301

Enlarged Kidney Parenchymal Volume Predicts Poor Kidney Outcomes in Advanced Stage Diabetic Nephropathy

Session Information

Category: Diabetic Kidney Disease

  • 702 Diabetic Kidney Disease: Clinical

Authors

  • Miura, Akane, Tokyo Jikeikai Ika Daigaku, Minato-ku, Tokyo, Japan
  • Okabe, Masahiro, Tokyo Jikeikai Ika Daigaku, Minato-ku, Tokyo, Japan
  • Sasaki, Takaya, Tokyo Jikeikai Ika Daigaku, Minato-ku, Tokyo, Japan
  • Okabayashi, Yusuke, Tokyo Jikeikai Ika Daigaku, Minato-ku, Tokyo, Japan
  • Haruhara, Kotaro, Tokyo Jikeikai Ika Daigaku, Minato-ku, Tokyo, Japan
  • Tsuboi, Nobuo, Tokyo Jikeikai Ika Daigaku, Minato-ku, Tokyo, Japan
  • Yokoo, Takashi, Tokyo Jikeikai Ika Daigaku, Minato-ku, Tokyo, Japan

Group or Team Name

  • Dept of Nephrology and Hypertension, The Jikei University School of Medicine.
Background

Early diabetic nephropathy (DN) is characterized by enlarged kidneys, but its clinical significance in advanced stages is not well understood. This study aimed to determine whether total kidney parenchymal volume (VTKP) is associated with renal outcomes in advanced stage DN patients with overt proteinuria.

Methods

VTKP was estimated in biopsy-proven DN patients using unenhanced computed tomography imaging. Clinicopathological findings, kidney morphometric parameters and renal outcomes were compared among tertile groups based on VTKP. The end point was defined as a 50% reduction in eGFR or ESKD.

Results

A total 81 patients were included in this study (84% male, median 55 years, eGFR 38 [24-52] ml/min/1.73m2, urinary protein 4.4 [2.2-7.0] g/day and median 1.8-year follow-up). Median values of VTKP were 111 [98-121], 156 [149-164], and 214 [191-243] cm3/kidney in the low, intermediate, and high VTKP groups. There were no differences in sex, hypertension, HbA1c and BMI among groups. Age showed a decreasing trend, while eGFR and proteinuria showed an increasing trend with VTKP. In the log-rank trend test, greater VTKP was significantly associated with poor renal outcomes (Figure). Interestingly, the associations between VTKP and renal outcomes were independent of age, eGFR and proteinuria levels at presentation (Table).

Conclusion

In patients with advanced stage DN, greater VTKP at presentation is associated with poor renal outcomes, independent of kidney function and proteinuria levels.

Cox proportional hazard model
VariableHazard ratio95% confidence intervalP value
Age, per year1.010.99-1.040.2
Urinary protein, per g/day1.101.04-1.16<0.001
eGFR, per mL/min/1.73m20.970.95-0.980.001
VTKP, per 10cm31.091.01-1.180.001

eGFR ≥50% decline or ESKD